LOS ANGELES, Jan. 4, 2021 /PRNewswire/ — Glancy Prongay & Murray LLP («GPM») reminds investors of the upcoming January 12, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Biogen, Inc. («Biogen» or the «Company») (NASDAQ: BIIB) securities between October 22, 2019 and […]
